Get started
Author

Ron Falcon

Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks
2012 · Judith A. Aberg, Pablo Tebas, et al. · AIDS Research and Human Retroviruses · 94
Sex-Based Outcomes of Darunavir–Ritonavir Therapy: A Single-Group Trial
2010 · Judith Currier, Dawn Averitt Bridge, et al. · Annals of Internal Medicine · 91
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV ‐1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
2013 · CD Zorrilla, R Wright, et al. · HIV Medicine · 53
Recruitment and Retention of Diverse Populations in Antiretroviral Clinical Trials: Practical Applications from the Gender, Race And Clinical Experience Study
2011 · Ron Falcon, Dawn Averitt Bridge, et al. · Journal of Women s Health · 49
PDF
Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected Women
2010 · Kristine Patterson, Steven Jennings, et al. · Antimicrobial Agents and Chemotherapy · 19
Assessing Darunavir/Ritonavir—Based Therapy in a Racially Diverse Population: 48-Week Outcomes From GRACE
2012 · Kimberly Y. Smith, Fernando Garcia, et al. · Journal of the National Medical Association · 6
Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy
2013 · Christos Tsoukas, Louise Gilbert, et al. · ISRN AIDS · 4
PDF
GRACE (Gender, Race And Clinical Experience): Outcomes by Race at Week 48
2009 · Kimberly Y. Smith, Fernando Herraiz García, et al. · 3
Limited positive predictive value of resistance testing in treatment-experienced patients
2005 · Diego Miralles, Ron Falcon, et al. · AIDS · 2
Efficacy and Safety of Oral Ibrexafungerp in Subjects with Vulvovaginal Candidiasis: Pooled Data from Two Phase 3, Randomized, Blinded, Study vs. Placebo (VANISH-303 and VANISH-306)
2022 · Jack Sobel, Paul Nyirjesy, et al. · American Journal of Obstetrics and Gynecology
Outcomes in Subpopulations from Pooled Phase 3 Clinical Studies of Oral Ibrexafungerp Versus Placebo in Patients with Vulvovaginal Candidiasis (VANISH 303 and 306)
2022 · Tosin Goje, Ron Falcon, et al. · American Journal of Obstetrics and Gynecology
Real-World Analysis of Oral Fluconazole 150 mg Prescribing Patterns in the Female United States Population and Projected National Utilization Estimates
2022 · Kate Sulham, Ron Falcon, et al. · American Journal of Obstetrics and Gynecology
GRACE (Gender, Race And Clinical Experience): 48-week results of darunavir/r-based therapy in the largest trial in north america to focus on treatment-experienced women
2009 · Kethleen Squires, Judith S. Currier, et al.
Works count: 15
Citation count: 321
H-index: 6
I10-index: 5
Year
Topic
Type